SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ABS-15G - Asset-backed securitizer report pursuant to Section 15G:
SEC Accession No. 0000950157-18-001130
Filing Date
2018-11-19
Accepted
2018-11-19 06:31:10
Documents
4
Period of Report
2018-11-16
Items
Item 2.01: Unregistered Entity: Findings and Conclusions of the Third Party Due Diligence Provider Obtained by the Issuer

Document Format Files

Seq Description Document Type Size
1 abs-15g.htm ABS-15G 14006
2 ex99-1.htm EX-99.1 46560
3 image0.jpg GRAPHIC 7604
4 image00001.jpg GRAPHIC 2775
  Complete submission text file 0000950157-18-001130.txt   77018
Mailing Address C/O DRC MGMT III LLC 2, MAPLES CORP SVCE PO BOX 309, UGLAND HOUSE GRAND CAYMAN E9 KY1-1104
Business Address C/O DRC MGMT III LLC 2, MAPLES CORP SVCE PO BOX 309, UGLAND HOUSE GRAND CAYMAN E9 KY1-1104 1-345-949-8066
Drug Royalty III LP 2 (Depositor) CIK: 0001674073 (see all company filings)

IRS No.: 981299836 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ABS-15G | Act: DF

Mailing Address C/O DRC MGMT III LLC 2, MAPLES CORP SVCE PO BOX 309, UGLAND HOUSE GRAND CAYMAN E9 KY1-1104
Business Address C/O DRC MGMT III LLC 2, MAPLES CORP SVCE PO BOX 309, UGLAND HOUSE GRAND CAYMAN E9 KY1-1104 1-345-949-8066
Drug Royalty III LP 2 (Filer) CIK: 0001674073 (see all company filings)

IRS No.: 981299836 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ABS-15G | Act: DF | File No.: 025-02786 | Film No.: 181191206